Trials / Unknown
UnknownNCT02994082
Treating Smokeless Tobacco Use in Rural Veterans
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 123 (actual)
- Sponsor
- Mark Vander Weg · Federal
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
This is a pilot study designed in an effort to develop and improve access to effective treatments for tobacco use in rural Veterans using a tailored intervention approach. Specifically, we will evaluate a combined behavioral and pharmacological smokeless tobacco cessation which concomitantly addresses comorbid issues commonly experienced by rural tobacco users including elevated depressive symptoms, risky alcohol use, and concerns about weight gain. The objectives are to: 1. Evaluate the feasibility of an individually-tailored telephone intervention for rural smokeless tobacco users 2. Examine the impact of the intervention on treatment utilization, patient satisfaction, and smokeless tobacco cessation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Tailored behavioral intervention | Participants will receive a standard six session cognitive behavioral intervention for smokeless tobacco cessation combined with supplemental treatment modules based on individual need and preferences. |
| BEHAVIORAL | Behavioral activation for elevated depressive symptoms | Participants with elevated depressive symptoms may receive this six session telephone-based behavioral activation intervention. |
| BEHAVIORAL | Post-cessation weight gain management | Participants with concerns about gaining weight after quitting smokeless tobacco use may receive this six session telephone-based behavioral self-management intervention designed to help attenuate post-cessation weight gain. |
| BEHAVIORAL | Alcohol use risk reduction | Participants engaging in risky alcohol use may receive this six session telephone-based behavioral intervention for reducing alcohol use. |
| DRUG | Nicotine replacement therapy - transdermal nicotine patch | Medication selection will be based on individual participant preferences, medical history, and contraindications. |
| DRUG | Nicotine replacement therapy - nicotine lozenge | Medication selection will be based on individual participant preferences, medical history, and contraindications. |
| DRUG | Nicotine replacement therapy - nicotine gum | Medication selection will be based on individual participant preferences, medical history, and contraindications. |
| DRUG | Bupropion sustained release | Medication selection will be based on individual participant preferences, medical history, and contraindications. |
| DRUG | Varenicline | Medication selection will be based on individual participant preferences, medical history, and contraindications. |
| DRUG | Combination nicotine replacement therapy | Medication selection will be based on individual participant preferences, medical history, and contraindications. Possible combinations include nicotine patch + nicotine lozenge and nicotine patch + nicotine gum. |
| DRUG | Combination nicotine replacement therapy + bupropion | Medication selection will be based on individual participant preferences, medical history, and contraindications. Possible combinations include nicotine patch + bupropion, nicotine gum + bupropion, and nicotine lozenge + bupropion. |
| BEHAVIORAL | Tobacco quit line | Referral to the Department of Veterans Affairs tobacco telephone quit line. |
| BEHAVIORAL | Educational materials | Information regarding the VA tobacco quit line and associated treatment services, self-help materials for tobacco cessation, and information about tobacco cessation medications available in the VA, |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2019-09-01
- Completion
- 2020-05-01
- First posted
- 2016-12-15
- Last updated
- 2019-07-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02994082. Inclusion in this directory is not an endorsement.